Edition:
United States

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

37.94USD
15 Dec 2017
Change (% chg)

$0.84 (+2.26%)
Prev Close
$37.10
Open
$37.28
Day's High
$38.00
Day's Low
$37.25
Volume
46,507
Avg. Vol
28,950
52-wk High
$44.38
52-wk Low
$13.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 7.81 -0.023
Jun '17 0.00 -0.697
FY 2016 Dec '16 17.53 1.122
Sep '16 0.00 -3.731
Jun '16 0.00 -1.702
Mar '16 0.00 -1.811
FY 2015 Dec '15 0.00 -0.678
Sep '15
Mar '15 0.00 -0.196
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.00 0.00 0.00 --
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 4 7.87 8.00 7.80 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-17 4 -0.68 -0.67 -0.69 --
Quarter Ending Mar-18 2 -0.64 -0.57 -0.71 --
Year Ending Dec-17 4 -2.13 -1.98 -2.50 --
Year Ending Dec-18 4 -2.71 -2.47 -2.95 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) -- 122.78 5.95
Price to Book (MRQ) 6.56 23.45 5.68
Price to Tangible Book (MRQ) 6.56 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 36.62 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 99.39 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 16.30 1.79 2.55
Current Ratio (MRQ) 16.33 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -10.94 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -- -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -- -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -- -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,314,532 851,801,741
Net Income/Employee (TTM) -- -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) -- 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -- -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -- -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 67.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Urogen Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.46%
# of Holders: 37
Total Shares Held: 5,595,685
3 Mo. Net Change: 281,087
# New Positions: 17
# Closed Positions: 4
# Increased Positions: 22
# Reduced Positions: 10
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.